Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02240979 · ClinicalTrials.gov registry record
Establishing a Non-invasive Method to Measure Your Heart's Performance
A clinical trial of Heart Failure, sponsored by Marie Csete MD, PhD.
- Completed
- Registry status
- 72
- Enrollment target
- 2
- Study locations
NCT02240979: Completed study of Heart Failure, sponsored by Marie Csete MD, PhD.
NCT02240979 is a study of Heart Failure that has completed, run by Marie Csete MD, PhD. The registered enrollment target is 72 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02240979, a study of Heart Failure, has completed, sponsored by Marie Csete MD, PhD.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to evaluate a new way to examine cardiac function, using software developed at Caltech. The experimental device is software loaded on an iPhone. The iPhone is used to capture a pulse (waveform) by simply placing the iPhone lightly over the neck where the carotid pulse can be felt. In this study the information collected from the iPhone app is compared to cardiac function data obtained from the current gold standard for measuring cardiac function, cardiac magnetic resonance imaging (MRI). Subjects referred from cardiologists will also generally have echocardiography information available for comparison with the iPhone app. For the study, subjects will have completely non-invasive studies done in one setting: The iPhone app to capture the waveforms (over carotid and radial (wrist) arteries), tonometry (another non-invasive method using a modified stethoscope), standard pulse oximetry, followed by a 30 minute MRI examination of the heart. A second complete study will be done about 6 months after the first. The complete study session takes about 1.5 hours.
Primary Outcome
Standard end-points of cardiac function such as chamber size and relaxation.
Conditions Studied
Interventions
- DEVICE cardiac MRI
Study Locations (2)
California
- Avicena LLC - Pasadena
- Huntington Medical Research Institutes MR Imaging Center - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2014-08 |
| Est. Completion | 2019-05 |
What the finished NCT02240979 record still lists
NCT02240979 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which cardiac MRI is the first listed.
NCT02240979 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02240979 about?
NCT02240979 is a clinical study titled "Establishing a Non-invasive Method to Measure Your Heart's Performance". The purpose of the study is to evaluate a new way to examine cardiac function, using software developed at Caltech. The experimental device is software loaded on an iPhone. The iPhone is used to capture a pulse (waveform) by simply placing the iPhone lightly over the neck where the carotid pulse can...
What is the current status of trial NCT02240979?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2014-08. Estimated completion is 2019-05.
What conditions does trial NCT02240979 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT02240979?
The interventions under investigation include: cardiac MRI (DEVICE).
Who is sponsoring clinical trial NCT02240979?
This trial is sponsored by Marie Csete MD, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02240979 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02240979's enrollment target sits among peer trials
72 240th of 397 higher than 156 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
- NCT03747458 · 72 participants · Phase 3
OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia